Robert LeBoyer Stock Analyst Profile - Noble Capital Markets Research Coverage - Stocknear

Robert LeBoyer

Stock Analyst at Noble Capital Markets

(3.33)
# 2792
Out of 5,504 analysts
20
Total ratings
Success rate
Average return

16 Stocks

Name Action PT Current % Upside Ratings Updated
TNXP Tonix Pharmaceutical...
Reiterates: Outperform
70 70
23.94 192.4% 2 Mar 20, 2025
NTRB Nutriband
Initiates Coverage On: Outperform
13
7.37 76.39% 1 Jan 22, 2025
GOVX Geovax Labs
Maintains: Outperform
6 10
0.57 1654.39% 2 Aug 19, 2024
UNCY Unicycive Therapeuti...
Initiates Coverage On: Outperform
60
4.61 1201.52% 1 Feb 14, 2024
CVKD Cadrenal Therapeutic...
Initiates Coverage On: Outperform
60
14.28 320.17% 1 Dec 18, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
10
2.83 253.36% 1 Sep 27, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
14
1.73 709.25% 1 Feb 21, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 1 Sep 20, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
150
n/a n/a 1 Oct 12, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
8
1.68 376.19% 2 Aug 19, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
120
0.73 16338.36% 1 Jan 25, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 1 Oct 5, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
12
9.95 20.6% 1 Sep 28, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
9900000
n/a n/a 1 Aug 24, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 1 Apr 10, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
15
3.65 310.96% 2 Mar 8, 2018